Manuel Ernesto Almaguer Tostado’s Post

Learn how a publicly traded gene therapy company struggled to identify an optimal vector design to carry forward after 15 rounds of empirical optimization over three years. By applying AI/ML models, Form Bio was able to identify four optimal vector designs within days that resulted in 91% full capsids. The company was able to advance a lead and backup candidate to next steps. Explore the methods and results: https://hubs.li/Q02LwKgs0 #VectorDiscovery #AAV #GeneTherapy #InSilico

Next generation medicine should be equipped by next generation of data strategy. Hear Cell and Gene Therapy specialists’ insights on how they adopt a long-term perspective to achieve commercial excellence at Reuters Events Pharma upcoming webinar: https://bit.ly/3OkH4Ly

Are sound waves the key to revolutionizing gene therapy? In this groundbreaking episode, we sit down with Gabriel Dumy, CTO and Co-founder at Kolibri, a company revolutionizing the way we grow and engineer cells at scale using acoustic waves. Gabriel discusses the challenges facing modern bioproduction and unveils an exciting solution that is setting the stage for the future of gene therapy.

Ever-evolving US cell & gene therapy market! (2023-2028) Anticipate a profound change in the U.S. cell & gene therapy market over the next five years. These therapies are set to take center stage, driving the market to expand almost seven times its current value. Want to dive deeper into these insights and how they can impact your stake in the healthcare revolution? Check out https://bit.ly/493vex1 #UScellandgenetherapymarket #cellandgenetherapymarket #focusreportsbyarizton #ariztonresearchreveals #marketresearch #researchreport #marketinsights #markettrends #marketsize #marketshare #marketgrowth #marketforecast #marketexpansion #healthcareandlifesciences

Rapid growth in cell and gene therapy (CGT) is leading scientists to consider how patient-centered treatments can be delivered uninterruptedly through a time-dependent and agile approach. Read our new BioPhorum publication by Maria Rende, PhD, MBioSci, Cell and Gene Therapy Expert, to learn the requirements of different CGT outbound supply chains. https://sar.to/jgy34 #SimplifyingProgress #InThisTogether #CellandGeneTherapy #AdvancedTherapies #CellTherapy #GeneTherapy

Find out how droplet digital PCR (ddPCR) is transforming gene therapy—and the data challenges holding it back. Our solution brief shows how TetraScience optimizes ddPCR workflows. Collect, search, and analyze results faster. Plus, unlock deeper insights with AI-native data. Learn more: https://lnkd.in/gCuPn2pT #TetraScience #genetherapy #ddPCR #ScientificDataAndAICloud #ScientificOutcomes

Next generation medicine should be equipped by next generation of data strategy. Hear Cell and Gene Therapy specialists’ insights on how they adopt a long-term perspective to achieve commercial excellence at Reuters Events Pharma upcoming webinar: https://bit.ly/3OkH4Ly

#FastFacts now available! #HEK293 suspension culture in stirred 3D-systems for #genetherapy development #Bioreactors can be a suitable option to establish optimal culture conditions during process development. The #Expi293F #cellline shows significant improvements over traditional #HEK293celllines due to its robust growth under suspension culture conditions and its stable and transient expression. In this FastFacts, Jorge Escobar (Senior Applications Specialist Cell & Gene Therapy Applications, Eppendorf, Inc.) demonstrates how Expi293F and single-use stirred-tank #bioreactors can establish optimal culture conditions for #AAV-based gene therapy applications Read below:

🧬 Dive into our latest solution brief to uncover how TetraScience is revolutionizing ddPCR workflows, addressing data challenges, and unlocking new possibilities. 🚀 Key Features: ✅ Optimize ddPCR workflows for enhanced efficiency ✨ AI-native data capabilities for deeper insights 🔍 Collect, search, and analyze results faster #GeneTherapy #ddPCR #DataOptimization #TetraScience #InnovationInScience #BiotechRevolution

Cell and gene therapy in the Asia-Pacific region https://lnkd.in/efNFUyFj learnings from local case studies. In this update, we share two case studies that explore how local innovators in the cell and gene therapy space in Asia-Pacific are addressing some of the major challenges for access in the region: that of overcoming complex manufacturing and delivery and improving affordability. https://lnkd.in/efNFUyFj #MarketAccess #HEOR #WeAreAvalereHealth